Trial Profile
A Multi-center, Randomized, Double-blind, Positive-control, Phase III Trial of the Efficacy and Safety of Clevudine.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Clevudine (Primary) ; Adefovir
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 29 Jul 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 29 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Sep 2010 New trial record